Andrea L. Arnett, Ph.D.
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
muscle gene therapy, DMDGoogle:
"Andrea Arnett"Parents
Sign in to add mentor| Jeffrey Chamberlain | grad student | 2011 | University of Washington | |
| (Transduction and tropism of rAAV6: Implications for gene therapy of neuromuscular disorders.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wilhite TJ, Routman D, Arnett AL, et al. (2018) Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysis. Bladder (San Francisco, Calif.). 5: e34 |
| Arnett AL, Konieczny P, Ramos JN, et al. (2014) Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells. Molecular Therapy. Methods & Clinical Development. 1 |
| Swiderski K, Shaffer SA, Gallis B, et al. (2014) Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting. Human Molecular Genetics. 23: 6697-711 |
| Arnett AL, Beutler LR, Quintana A, et al. (2013) Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction. Gene Therapy. 20: 497-503 |
| Arnett AL, Garikipati D, Wang Z, et al. (2011) Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector. Frontiers in Microbiology. 2: 220 |
| Judge LM, Arnett AL, Banks GB, et al. (2011) Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice. Human Molecular Genetics. 20: 4978-90 |
| Wang Z, Storb R, Lee D, et al. (2010) Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 617-24 |
| Arnett AL, Chamberlain JR, Chamberlain JS. (2009) Therapy for neuromuscular disorders. Current Opinion in Genetics & Development. 19: 290-7 |